Literature DB >> 22399420

Mitochondria and reactive oxygen species. Which role in physiology and pathology?

Giorgio Lenaz1.   

Abstract

Oxidative stress is among the major causes of toxicity due to interaction of Reactive Oxygen Species (ROS) with cellular macromolecules and structures and interference with signal transduction pathways. The mitochondrial respiratory chain, specially from Complexes I and III, is considered the main origin of ROS particularly under conditions of high membrane potential, but several other sources may be important for ROS generation, such as mitochondrial p66(Shc), monoamine oxidase, α-ketoglutarate dehydogenase, besides redox cycling of redox-active molecules. ROS are able to oxidatively modify lipids, proteins, carbohydrates and nucleic acids in mitochondria and to activate/inactivate signalling pathways by oxidative modification of redox-active factors. Cells are endowed with several defence mechanisms including repair or removal of damaged molecules, and antioxidant systems, either enzymatic or non-enzymatic. Oxidative stress is at the basis of ageing and many pathological disorders, such as ischemic diseases, neurodegenerative diseases, diabetes, and cancer, although the underlying mechanisms are not always completely understood.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399420     DOI: 10.1007/978-94-007-2869-1_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  68 in total

Review 1.  To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Authors:  C Piccoli; F Agriesti; R Scrima; F Falzetti; M Di Ianni; N Capitanio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 2.  Autophagy and genomic integrity.

Authors:  A T Vessoni; E C Filippi-Chiela; C Fm Menck; G Lenz
Journal:  Cell Death Differ       Date:  2013-08-09       Impact factor: 15.828

Review 3.  Oxidative stress in chronic lung disease: From mitochondrial dysfunction to dysregulated redox signaling.

Authors:  Albert van der Vliet; Yvonne M W Janssen-Heininger; Vikas Anathy
Journal:  Mol Aspects Med       Date:  2018-08-22

4.  Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS.

Authors:  Ruohan Zhang; Hongyu Qiao; Suning Chen; Xu Chen; Kefeng Dou; Li Wei; Jian Zhang
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

5.  Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates.

Authors:  Sarah McMahon; Thomas LaFramboise
Journal:  Carcinogenesis       Date:  2014-01-18       Impact factor: 4.944

6.  Oxidative cross-linking of proteins to DNA following ischemia-reperfusion injury.

Authors:  Arnold Groehler; Stefan Kren; Qinglu Li; Maggie Robledo-Villafane; Joshua Schmidt; Mary Garry; Natalia Tretyakova
Journal:  Free Radic Biol Med       Date:  2018-03-11       Impact factor: 7.376

Review 7.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

8.  Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I.

Authors:  Evelina Maranzana; Giovanna Barbero; Anna Ida Falasca; Giorgio Lenaz; Maria Luisa Genova
Journal:  Antioxid Redox Signal       Date:  2013-06-28       Impact factor: 8.401

Review 9.  Phytochemicals in Ischemic Stroke.

Authors:  Joonki Kim; David Yang-Wei Fann; Raymond Chee Seong Seet; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2016-05-18       Impact factor: 3.843

10.  Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Authors:  Yi Che; Yong-Hua Cui; Hua Tan; Ana C Andreazza; L Trevor Young; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.